Literature DB >> 18818413

Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.

Sara Bretschger Seidelmann1, Chaoling Kuo, Nick Pleskac, Jennifer Molina, Scott Sayers, Rong Li, Jing Zhou, Pamela Johnson, Kathleen Braun, Christina Chan, Daniel Teupser, Jan L Breslow, Thomas N Wight, Alan R Tall, Carrie L Welch.   

Abstract

OBJECTIVE: Susceptibility to atherosclerosis is genetically complex, and modifier genes that do not operate via traditional risk factors are largely unknown. A mouse genetics approach can simplify the genetic analysis and provide tools for mechanistic studies. METHODS AND
RESULTS: We previously identified atherosclerosis susceptibility QTL (Athsq1) on chromosome 4 acting independently of systemic risk factors. We now report confirmation of this locus in congenic strains carrying the MOLF-derived susceptibility allele in the C57BL/6J-Ldlr(-/-) genetic background. Homozygous congenic mice exhibited up to 4.5-fold greater lesion area compared to noncongenic littermates (P<0.0001). Analysis of extracellular matrix composition revealed prominent accumulation of versican, a presumed proatherogenic matrix component abundant in human lesions but almost absent in the widely-used C57BL/6 murine atherosclerosis model. The results of a bone marrow transplantation experiment suggested that both accelerated lesion development and versican accumulation are mediated, at least in part, by macrophages. Interestingly, comparative mapping revealed that the Athsq1 congenic interval contains the mouse region homologous to a widely-replicated CHD locus on human chromosome 9p21.
CONCLUSIONS: These studies confirm the proatherogenic activity of a novel gene(s) in the MOLF-derived Athsq1 locus and provide in vivo evidence for a causative role of versican in lesion development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818413      PMCID: PMC2784896          DOI: 10.1161/ATVBAHA.108.176800

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  45 in total

1.  Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C).

Authors:  C A de La Motte; V C Hascall; A Calabro; B Yen-Lieberman; S A Strong
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion.

Authors:  Thomas S Wilkinson; Steven L Bressler; Stephen P Evanko; Kathleen R Braun; Thomas N Wight
Journal:  J Cell Physiol       Date:  2006-02       Impact factor: 6.384

3.  Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.

Authors:  Joan M Lemire; Christina K Chan; Steven Bressler; John Miller; Richard G LeBaron; Thomas N Wight
Journal:  J Cell Biochem       Date:  2007-06-01       Impact factor: 4.429

4.  A common variant on chromosome 9p21 affects the risk of myocardial infarction.

Authors:  Anna Helgadottir; Gudmar Thorleifsson; Andrei Manolescu; Solveig Gretarsdottir; Thorarinn Blondal; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Asgeir Sigurdsson; Adam Baker; Arnar Palsson; Gisli Masson; Daniel F Gudbjartsson; Kristinn P Magnusson; Karl Andersen; Allan I Levey; Valgerdur M Backman; Sigurborg Matthiasdottir; Thorbjorg Jonsdottir; Stefan Palsson; Helga Einarsdottir; Steinunn Gunnarsdottir; Arnaldur Gylfason; Viola Vaccarino; W Craig Hooper; Muredach P Reilly; Christopher B Granger; Harland Austin; Daniel J Rader; Svati H Shah; Arshed A Quyyumi; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

Review 5.  Versican degradation and vascular disease.

Authors:  Richard D Kenagy; Anna H Plaas; Thomas N Wight
Journal:  Trends Cardiovasc Med       Date:  2006-08       Impact factor: 6.677

6.  PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation.

Authors:  Peng-Sheng Zheng; Dana Vais; David Lapierre; Yao-Yun Liang; Vivian Lee; Bing L Yang; Burton B Yang
Journal:  J Cell Sci       Date:  2004-11-02       Impact factor: 5.285

7.  Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

Authors:  Seongah Han; Chien-Ping Liang; Tracie DeVries-Seimon; Mollie Ranalletta; Carrie L Welch; Kadesha Collins-Fletcher; Domenico Accili; Ira Tabas; Alan R Tall
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

8.  A common allele on chromosome 9 associated with coronary heart disease.

Authors:  Ruth McPherson; Alexander Pertsemlidis; Nihan Kavaslar; Alexandre Stewart; Robert Roberts; David R Cox; David A Hinds; Len A Pennacchio; Anne Tybjaerg-Hansen; Aaron R Folsom; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

9.  An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction.

Authors:  Gong-Qing Shen; Lin Li; Domenico Girelli; Sara B Seidelmann; Shaoqi Rao; Chun Fan; Jeong Euy Park; Quansheng Xi; Jing Li; Ying Hu; Oliviero Olivieri; Kandice Marchant; John Barnard; Roberto Corrocher; Robert Elston; June Cassano; Susan Henderson; Stanley L Hazen; Edward F Plow; Eric J Topol; Qing K Wang
Journal:  Am J Hum Genet       Date:  2007-08-31       Impact factor: 11.025

10.  Genomewide association analysis of coronary artery disease.

Authors:  Nilesh J Samani; Jeanette Erdmann; Alistair S Hall; Christian Hengstenberg; Massimo Mangino; Bjoern Mayer; Richard J Dixon; Thomas Meitinger; Peter Braund; H-Erich Wichmann; Jennifer H Barrett; Inke R König; Suzanne E Stevens; Silke Szymczak; David-Alexandre Tregouet; Mark M Iles; Friedrich Pahlke; Helen Pollard; Wolfgang Lieb; Francois Cambien; Marcus Fischer; Willem Ouwehand; Stefan Blankenberg; Anthony J Balmforth; Andrea Baessler; Stephen G Ball; Tim M Strom; Ingrid Braenne; Christian Gieger; Panos Deloukas; Martin D Tobin; Andreas Ziegler; John R Thompson; Heribert Schunkert
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245

View more
  17 in total

1.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.

Authors:  Zhimin Zhang; Jessica S Rowlan; Qian Wang; Weibin Shi
Journal:  Circ Cardiovasc Genet       Date:  2012-01-31

3.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

4.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

5.  Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation.

Authors:  Mervyn J Merrilees; Brent W Beaumont; Kathleen R Braun; Anita C Thomas; Inkyung Kang; Aleksander Hinek; Alberto Passi; Thomas N Wight
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

6.  Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

Authors:  Chao-Ling Kuo; Andrew J Murphy; Scott Sayers; Rong Li; Laurent Yvan-Charvet; Jaeger Z Davis; Janakiraman Krishnamurthy; Yan Liu; Oscar Puig; Norman E Sharpless; Alan R Tall; Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

7.  Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation.

Authors:  Shreya Shukla; Rekha Nair; Marsha W Rolle; Kathleen R Braun; Christina K Chan; Pamela Y Johnson; Thomas N Wight; Todd C McDevitt
Journal:  J Histochem Cytochem       Date:  2009-12-21       Impact factor: 2.479

8.  Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.

Authors:  Alan R Tall; Nan Wang; Andrew J Murphy; Samuel Funt; Darren Gorman
Journal:  Circ Res       Date:  2013-04-23       Impact factor: 17.367

9.  Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.

Authors:  Christin E Burd; William R Jeck; Yan Liu; Hanna K Sanoff; Zefeng Wang; Norman E Sharpless
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

10.  Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.

Authors:  Wei Wang; Seon Oh; Mark Koester; Sandra Abramowicz; Nan Wang; Alan R Tall; Carrie L Welch
Journal:  Circ Cardiovasc Genet       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.